Some proteins synthesized by growing eukaryotic cells are transferred along unidirectional pathways of molecular chaperones until the risk of aggregation has decreased and they can be released safely. Mature proteins denatured by stress may instead be handled by chaperones acting in branched, reversible networks.
Recent work with growing yeast [3, 4] and Chinese hamster ovary (CHO) cells [5] suggests that chaperones binding to newly synthesized protein chains direct these chains efficiently along a linear pathway that acts as a folding compartment, and do not permit their release into the intracellular media (the cytosol and the mitochondrial matrix) in partially folded states until the danger of aggregation of such states has receded ( Figure 1a ). This 'chaperone pathway' view contrasts with a 'network' model ( Figure 1b ), based on in vitro reconstitution experiments [6] and in vivo observations with non-growing Xenopus oocytes [7] , in which partially folded proteins are released into the soluble cytosolic medium to compete for binding to different chaperones. The network model may be more applicable to the refolding of stress-denatured proteins than to the folding of newly synthesized proteins in cells growing under normal conditions [6] .
Networks versus pathways
The idea that partially folded and aggregation-prone proteins may normally be released into the soluble intracellular medium runs counter to the conclusion from prokaryotic genetic experiments, which showed that one of the major functions both of the cage-like GroEL chaperonin and of DnaK, the Escherichia coli homologue of the eukaryotic heat-shock protein Hsp70, is to prevent the aggregation of such proteins [2] . Nevertheless, release of partially folded chains from GroEL into the bulk medium, followed by rebinding to other GroEL molecules, has been demonstrated with reconstituted systems in vitro and this has led to the iterative annealing model for GroEL action [8] . In this model, the role of GroEL is to partly unfold misfolded proteins and then release them into the bulk medium to allow them another chance to fold correctly in that medium. In vitro work from other laboratories supports an alternative sequestration model, in which partially folded chains are retained individually inside the central cage of the GroEL chaperonin by a cap of GroES protein; they then continue to fold, and are released from the cage only when the danger of aggregation with similar chains has passed [2, 9] .
These two models are not mutually exclusive, given that both describe what has been observed under a given set of conditions in vitro, and it is at least conceivable that each model has evolved to operate with its own distinct spectrum of protein substrates that differ in their susceptibility to aggregation. The issue is whether the sequestration model predominates in vivo, as some suggest [2] , or whether, in addition, partially folded proteins cycle between GroEL and DnaK in the soluble intracellular medium [9] . The partially folded states of some proteins are not prone to aggregation and are not recognised by chaperones; this debate thus concerns only the 10-20% of newly synthesized proteins that bind to the GroEL and TRiC (TCP-1-containing ring complex) chaperonins, in E. coli and certain mammalian cells, respectively [10] .
Until the recent work [3] [4] [5] , the strongest argument that the sequestration model is likely to predominate for newly synthesized proteins in vivo was a theoretical one, based on the prediction that the physical phenomenon of macromolecular crowding operating inside cells would greatly enhance the probability of aggregation of partially folded proteins [2, 11] . Aggregation is commonly observed during the refolding of some denatured proteins, even though the buffers used are uncrowded compared to intracellular media. If aggregation is an even more serious problem inside the cell than it is in vitro, it seems likely that different chaperones acting at various points during the synthesis of protein chains will transfer the chains efficiently between them along a defined sequential pathway, rather than release them into a soluble pool. But it has been shown recently that denatured firefly luciferase can fold correctly while shuffling back and forth between the DnaK and GroEL chaperones in a pure reconstituted in vitro system [6] , leading the authors to suggest that chaperonemediated protein folding in the cell is not necessarily unidirectional, but instead may constitute a lateral network of co-operating chaperones. Thus, the debate turns on how far conclusions based on observations made using various in vitro systems reflect what happens in the intact cell.
Such disputes cannot be resolved by yet more observations on standard protein refolding systems: they require the use either of in vitro systems that reflect intracellular conditions more closely than pure chaperones mixed in uncrowded buffers or of relevant in vivo systems. Strong evidence favouring the chaperone pathway model for newly synthesized cytosolic proteins has now been provided by the use of mutant GroEL molecules expressed inside both yeast [3] and CHO cells [5] , and from studies of the folding of newly synthesized luciferase imported into yeast mitochondria, both in vivo and 'in organello' [4] .
Evidence for the pathway model inside mitochondria
Luciferase is made in nature by the cytosolic ribosomes of the firefly, and it is then transported into peroxisomes. When fused with a mitochondrial targeting signal and expressed from a plasmid in the cytosol of yeast cells, luciferase chains appear inside the mitochondria, where they first bind to Hsp70 (the mitochondrial DnaK homologue) and then to mitochondrial GroEL [3] . About 90% of these chains remain bound to GroEL in an enzymically inactive state, and only about 10% appear in the mitochondrial matrix where their enzymic activity can be measured. Thus, although luciferase bound to GroEL in vitro can be released into the medium to fold correctly, provided DnaK is also present to prevent aggregation [6] , this is not the case for luciferase imported into yeast mitochondria, where the chaperone pathway operates in a unidirectional manner [3] . What determines unidirectionality in this case is not clear, but it may reflect the increase in association between partly folded luciferase and GroEL that is predicted to result from the crowded state of the mitochondrial matrix. This interpretation is supported by the report that the addition of the synthetic crowding agents Ficoll and dextran to a refolding system containing GroEL and rhodanese inhibits the release of partially folded rhodanese chains from GroEL into the medium [12] . Thus, while iterative annealing is a feature of some in vitro refolding systems, it may not apply to proteins newly synthesized in vivo.
A criticism of all experiments involving firefly luciferase and GroEL is that luciferase is neither a natural substrate for GroEL nor capable of being released into its central cage to allow correct folding, probably because of its size (62 kDa). Nevertheless, the different behaviour of luciferase in these two reports cautions against extrapolating to the in vivo situation observations made with reconstituted in vitro systems.
Evidence for the pathway model in eukaryotic cytosol
If partially folded proteins capable of being recognised by GroEL are released into the cytosol shortly after their synthesis, it should be possible to detect them by utilising the properties of a mutant form of GroEL called 'trap GroEL'. This GroEL mutant, D87K, is defective in ATP hydrolysis, and as a result it binds to partially folded proteins with the same affinity as wild-type GroEL but is unable to release them, whether ATP is present or not; it acts as a trap for partially folded chains [7] . Trapping of such chains would be expected to inhibit cell growth since it would R138 Current Biology, Vol 9 No 4
Figure 1
Comparison of the pathway (a) and network (b) models for the chaperone-assisted folding of newly synthesized proteins. The red line represents a polypeptide chain, while 'small chaperones 1 and 2' represent chaperones of the DnaK/DnaJ type [2, 10] . The term 'unfolded' refers to the ensemble of partially folded states that free chains may adopt before reaching their final conformations. The critical distinction between the two models is the extent to which unfolded states are released into the intracellular medium while they are prone to aggregation. Expression of trap GroEL in the cytosol of either yeast [4] or CHO cells [5] does not inhibit their growth, nor does it result in the trapping of the vast majority (> 99%) of newly synthesized protein chains labelled with 35 S-methionine or a reduction in the rate of folding of newly synthesized actin. But do these negative effects of trap GroEL mean that partially folded proteins are not released into the cytosol, or does it result from a failure of the trap GroEL to bind to such proteins under intracellular conditions?
Evidence that trap GroEL is functional in vivo
Trap GroEL could fail to function for several possible reasons. It could be expressed at too low a level to compete effectively with the endogenous chaperonin TriC in the eukaryotic cytosol, it could become saturated with pre-existing unlabelled proteins before the 35 S-methionine is applied, it could release bound proteins during the extraction procedures, or it could simply be inactivated by some unknown process. Evidence is available to rule out each of these explanations.
From earlier experiments in vitro, GroEL is known to have a higher affinity for partially folded actin than does TriC, while the level of expression in yeast cells is such that the trap GroEL is present in the cytosol at ten times the concentration of TriC [3] . Moreover, the trap GroEL present in extracts of yeast cells is capable of binding partially folded actin in a quantitative manner, indicating that it is fully active in these extracts. A positive demonstration that trap GroEL is active in vivo is provided for both yeast and CHO cells. Thus, actin synthesized inside yeast cells in a form incapable of correct folding due to a mutation in TRiC is found in cell extracts bound to trap GroEL [4] , while treatment of CHO cells with either a proline analogue or heat stress generates misfolded proteins that similarly can be detected bound to extracted trap GroEL [5] .
These observations strongly support the chaperone pathway model for proteins newly synthesized by growing yeast and CHO cells; but the mechanisms that ensure the high integrity of this folding compartment in these cells remain to be determined. By contrast, injection of trap GroEL into the cytoplasm of non-growing Xenopus oocytes inhibits the folding of newly synthesized actin; technical limitations prevented the isolation from these oocytes of trap GroEL bound to actin [7] , so the mechanism of this inhibition is unclear. Future work should test the possibility that the efficiency with which the chaperone pathway transfers partially folded proteins between its members varies with cell type and with the cell's metabolic activity.
